CymitQuimica logo

CAS 923950-08-7

:

dulaglutide

Description:
Dulaglutide is a synthetic peptide and a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily used in the management of type 2 diabetes. It is characterized by its ability to enhance insulin secretion in response to elevated blood glucose levels, thereby aiding in glycemic control. The substance is administered via subcutaneous injection and has a prolonged half-life due to its resistance to enzymatic degradation, allowing for once-weekly dosing. Dulaglutide is composed of 44 amino acids and features a modified structure that includes a linker and a fatty acid moiety, which contributes to its pharmacokinetic properties. It is known to promote weight loss and has cardiovascular benefits, making it a valuable option in diabetes management. Common side effects may include gastrointestinal disturbances, such as nausea and diarrhea. As with any medication, it is essential for patients to discuss potential risks and benefits with their healthcare provider.
Formula:C20H17N3O3
Synonyms:
  • N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-(2-furyl)-6-methylimidazo[1,2-a]pyridin-3-amine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.